XML 57 R45.htm IDEA: XBRL DOCUMENT v3.23.1
Balance Sheet Components - Accrued and Other Current Liabilities (Details) - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Balance Sheet Components    
Accrued commercial and research and development manufacturing $ 9,677 $ 21,774
Accrued co-development costs payable to Junshi Biosciences 3,480 8,356
Lease liabilities, current 4,436 4,318
Accrued other 14,464 15,649
Total Accrued and other current liabilities $ 32,057 $ 50,097